News
Parents won't be able to vaccinate healthy children 6 months to 5 years old if the FDA pulls Pfizer's COVID-19 vaccine ...
Daily Express US on MSN3d
Pfizer's Covid-19 vaccine availability for children under 5 faces potential FDA roadblock
The landscape of COVID-19 vaccinations for children is shifting in the US. How will this affect the upcoming virus season?
7don MSN
Vaccinating young children against Covid-19 may be more challenging this respiratory virus season
Parents in the United States who want to vaccinate their young children against Covid-19 this fall may face a growing set of ...
Coronavirus infections are climbing again, marking another summer wave as children go back to school. But this uptick arrives ...
For the first time in 30 years, the American Academy of Pediatrics is substantially diverging from U.S. government vaccine ...
Under Robert F. Kennedy Jr., federal officials may withdraw an endorsement for the vaccine in younger children.
The Food and Drug Administration could pull Pfizer's coronavirus vaccine emergency authorization for children under age 5.
It's important to note, however, that Pfizer's vaccine requires two doses administered several weeks apart to reach 95% efficacy. So 100 million doses would vaccinate half the number of people.
Currently, children ages 5 to 11 are eligible for two pediatric doses of Pfizer's Covid-19 vaccine but are not yet eligible for a booster. Pfizer is testing a third dose in that age group now.
Drugmaker Pfizer said Friday that as government contracts come to an end, possibly by early next year, its COVID-19 vaccine will be sold for $110 to $130 per dose.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback